Neuroleptic malignant syndrome: response to dantrolene sodium.
D003620:Dantrolene / Q000627:therapeutic use*; D005334:Fever / Q000139:chemically induced*; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced*; D013577:Syndrome
D003620:Dantrolene; D006220:Haloperidol